SDC1 and coronary artery disorder: This is related to in vitro studies showing thinning of the endothelial glycocalyx in areas of impaired blood flow associated with atherosclerotic plaque formation [45] and increased levels of hyaluronic acid and syndecan-1 in the plasma of patients with coronary artery disease [48].